NovoCure Limited - Ordinary Shares (NVCR): $154.01

-9.99 (-6.09%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

NovoCure Ltd (NVCR) Price Targets From Analysts

Use the tables below to see what analysts covering NovoCure Ltd think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
7 $250 $120 $192 $189.5 1.32%

The Trend in the Analyst Price Target


Over the past 91 days, NVCR's average price target has gone up $0.86.

NVCR reports an average of -5.79% for its upside potential over the past 14 months.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-07-17 7 250 120 192.00 182.57 5.17%
2021-07-10 7 250 120 192.00 194.55 -1.31%
2021-07-03 7 250 110 189.86 184.15 3.1%
2021-06-23 7 250 110 191.71 225.58 -15.01%
2021-06-13 7 250 110 191.71 216.28 -11.36%
2021-06-05 7 250 110 191.71 205.71 -6.81%
2021-05-19 7 250 110 191.71 176.48 8.63%
2021-04-30 7 250 110 192.57 204.10 -5.65%
2021-04-25 7 250 110 192.57 207.63 -7.25%
2021-04-17 7 250 110 191.14 192.50 -0.71%
2021-04-07 8 225 103 154.88 131.70 17.6%
2021-04-03 8 225 103 154.88 133.35 16.15%
2021-03-20 8 225 103 154.88 141.69 9.31%
2021-03-13 8 225 103 154.88 138.29 12%
2021-03-05 8 225 103 154.88 129.28 19.8%
2021-02-22 8 225 88 150.13 181.04 -17.07%
2021-02-20 8 225 88 150.13 190.17 -21.05%
2021-02-13 8 225 88 150.13 189.65 -20.84%
2021-02-06 8 225 88 150.13 175.85 -14.63%
2021-01-30 8 225 88 150.13 160.96 -6.73%
2021-01-23 8 200 88 137.75 169.10 -18.54%
2021-01-16 8 200 88 136.00 167.55 -18.83%
2021-01-09 8 200 88 129.88 170.38 -23.77%
2021-01-02 8 200 86 126.00 173.04 -27.18%
2020-12-18 8 200 86 126.00 160.19 -21.34%
2020-12-10 8 200 86 126.00 168.18 -25.08%
2020-12-07 8 200 86 126.00 152.33 -17.28%
2020-11-28 8 200 86 126.00 126.84 -0.66%
2020-10-29 8 200 86 126.00 123.27 2.21%
2020-09-29 8 200 73 107.12 109.00 -1.72%
2020-09-22 8 200 73 107.38 104.15 3.1%
2020-09-17 7 125 73 94.14 108.98 -13.62%
2020-07-30 7 93 73 82.43 76.17 8.22%
2020-07-14 7 90 60 78.57 NA NA%
2020-07-07 7 90 60 78.57 NA NA%
2020-06-21 7 90 62 78.86 NA NA%
2020-06-21 8 90 62 78.75 NA NA%
2020-06-20 7 90 62 78.86 NA NA%
2020-05-28 7 90 62 78.86 NA NA%

NVCR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.06 0 2 5 1 1 9

The Trend in the Broker Recommendations


Over the past 30 days, NVCR's average broker recommendation rating worsened by 0.11.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • The average analyst price target of NVCR is greater than 93.65% of all US stocks.
  • The upside potential (average analyst target price relative to current price) of NVCR is higher than 10.62% of Healthcare stocks.
  • NovoCure Ltd's variance in analysts' estimates is less than 10.78% of Medical Equipment stocks.
  • The number of analysts covering the stock of NVCR is greater than 10.81% of stocks in the large market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Medical Equipment industry with the ratings most similar to NovoCure Ltd are RMD, EW and MSA.

Is NVCR a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7489 seconds.